Literature DB >> 8025899

A prospective study of endogenous hormones and breast cancer.

K J Helzlsouer1, A J Alberg, T L Bush, C Longcope, G B Gordon, G W Comstock.   

Abstract

To examine the association prospectively between endogenous hormones and breast cancer, a population-based, nested case-control study was conducted using serum collected in 1974. Serum hormone levels among 51 women, who subsequently developed breast cancer, were compared with controls matched on age and time since last menstrual period. The levels of estrogens, progesterone, sex-hormone binding globulin, and androstenedione were compared between cases and controls. No statistically significant differences in endogenous hormones levels were observed between women who subsequently developed breast cancer and controls. Despite the fact that risk factors for breast cancer implicated endogenous hormones, especially estrogen, in the etiology of this disease, our study failed to demonstrate a statistically significant association between endogenous hormones and the risk of breast cancer. If there is an association between endogenous hormones and breast cancer, the magnitude of the effect is weak.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025899

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  49 in total

1.  Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women.

Authors:  A Heather Eliassen; Donna Spiegelman; Xia Xu; Larry K Keefer; Timothy D Veenstra; Robert L Barbieri; Walter C Willett; Susan E Hankinson; Regina G Ziegler
Journal:  Cancer Res       Date:  2011-12-05       Impact factor: 12.701

Review 2.  The role of estrogen in the initiation of breast cancer.

Authors:  J Russo; Irma H Russo
Journal:  J Steroid Biochem Mol Biol       Date:  2006-12       Impact factor: 4.292

3.  Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-24       Impact factor: 4.292

4.  Silencing MAP3K1 expression through RNA interference enhances paclitaxel-induced cell cycle arrest in human breast cancer cells.

Authors:  Pinghua Hu; Qin Huang; Zhihua Li; Xiaobo Wu; Qianwen Ouyang; Jun Chen; Yali Cao
Journal:  Mol Biol Rep       Date:  2013-11-21       Impact factor: 2.316

5.  Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal women.

Authors:  Kannan Rangiah; Sumit J Shah; Anil Vachani; Eugene Ciccimaro; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2011-05-15       Impact factor: 2.419

Review 6.  Circulating sex steroids and breast cancer risk in premenopausal women.

Authors:  Susan E Hankinson; A Heather Eliassen
Journal:  Horm Cancer       Date:  2010-02-09       Impact factor: 3.869

Review 7.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

8.  Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study.

Authors:  Christy G Woolcott; Yurii B Shvetsov; Frank Z Stanczyk; Lynne R Wilkens; Kami K White; Christian Caberto; Brian E Henderson; Loïc Le Marchand; Laurence N Kolonel; Marc T Goodman
Journal:  Endocr Relat Cancer       Date:  2010-02-18       Impact factor: 5.678

9.  Body fatness throughout the life course and the incidence of premenopausal breast cancer.

Authors:  Fei Xue; Bernard Rosner; Heather Eliassen; Karin B Michels
Journal:  Int J Epidemiol       Date:  2016-07-27       Impact factor: 7.196

10.  Urinary endogenous sex hormone levels and the risk of postmenopausal breast cancer.

Authors:  N C Onland-Moret; R Kaaks; P A H van Noord; S Rinaldi; T Key; D E Grobbee; P H M Peeters
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.